Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody

Free Radical Research

Volumn 45, Issue 6, 2011, Pages 662-671

  Liu, Beiyi ^a   Hou, Xiaorui ^a   Zhou, Qiugen ^a   Tian, Jianwei ^a   Zhu, Ping ^a   Xu, Jie ^a   Hou, Fanfan ^a   Fu, Ning ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Advanced oxidation protein products (AOPP); chronic kidney disease (CKD); immunoassay; monoclonal antibody (mAb); oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; DICHLOROFLUORESCEIN; FIBRINOGEN; HYPOCHLOROUS ACID; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3F2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN LOCALIZATION; RAT; WESTERN BLOTTING;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BINDING, COMPETITIVE; BLOOD PROTEINS; CELLS, CULTURED; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MICE; MICE, INBRED BALB C; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 79959424226     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.564167     Document Type: Article

References (25)

1. Saran R, Hedgeman E, Huseini M, Stack A, Shahinian V. Surveillance of chronic kidney disease around the world: tracking and reining in a global problem. Adv Chronic Kidney Dis 2010;17:271-281.
2. Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 2010;17:215-224.
3. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49: 1304-1313. (Pubitemid 26166404)
4. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006;26:1156-1162. (Pubitemid 43732127)
5. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol 2007;18:528-538. (Pubitemid 46193318)
6. Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP, Tian JW. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPHdependent mechanisms. Kidney Int 2009;76:1148-1160.
7. Wei XF, Zhou QG, Hou FF, Liu BY, Liang M. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 2009;296:F427-F437.
8. Kalousova M, Skrha J, Zima T. Advanced glycation endproducts and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51:597-604. (Pubitemid 36168668)
9. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002; 162:221-225. (Pubitemid 34327362)
10. Baskol M, Baskol G, Kocer D, Ozbakir O, Yucesoy M. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis. J Clin Gastroenterol 2008; 42:687-691.
11. Chandramathi S, Suresh K Anita ZB, Kuppusamy UR. Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. J Cancer Res Clin Oncol 2009;135: 319-323.
12. Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, Zhang X. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 2008;149:1829-1839. (Pubitemid 351468323)
13. Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B. Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors. Clin Chim Acta 2007;379: 87-94. (Pubitemid 46366973)
14. Selmeci L, Szekely M, Soos P, Seres L, Klinga N, Geiger A, Acsady G. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res 2006;40:952-958. (Pubitemid 44480558)
15. Hawkins CL, Pattison DI, Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 2003;25:259-274. (Pubitemid 38041264)
16. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999;27:612-616. (Pubitemid 29408648)
17. Noordzij MJ, Lefrandt JD, Smit AJ. Advanced glycation end products in renal failure: an overview. J Ren Care 2008;34: 207-212.
18. Hawkins CL, Davies MJ. Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogencentred radicals and their role in protein fragmentation. Biochem J 1999;40:539-548. (Pubitemid 29286577)
19. Witko-Sarsat V, Friedlander M, Nguyen KT, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161: 2524-2532. (Pubitemid 28397070)
20. Vissers MC, Winterbourn CC. Oxidative damage to fibronectin. I. The effects of the neutrophil myeloperoxidase system and HOCl. Arch Biochem Biophys 1991;285:53-59.
21. Kawakami A, Kubota K, Yamada N, Tagami U, Takehana K, Sonaka I, Suzuki E, Hirayama K. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS J 2006;273:3346-3357. (Pubitemid 43990937)
22. Malle E, Hazell L, Stocker R, Sattler W, Esterbauer H, Waeg G. Immunologic detection and measurement of hypochloritemodifi ed LDL with specifi c monoclonal antibodies. Arterioscler Thromb Vasc Biol 1995;15:982-989.
23. Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ. Immunohistochemical evidence for the myeloperoxidase/ H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochloritemodifi ed proteins. Eur J Biochem 2000;267:4495-4503. (Pubitemid 30461082)
24. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modifi ed proteins in human atherosclerotic lesions. J Clin Invest 1996;97:1535-1544. (Pubitemid 26097044)
25. Grone HJ, Grone EF, Malle E. Immunohistochemical detection of hypochlorite-modifi ed proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 2002;82: 5-14. (Pubitemid 34072641)